IP Library › Assignment 069193/0925
Patent Assignment
Reel/Frame 069193/0925

Assignment of Assignor's Interest

Recorded: 2024-10-21 Pages: 24
Assignor
INFINITY PHARMACEUTICALS, INC.
Executed: 2024-03-01
Assignee
TWELVE THERAPEUTICS, INC.
C/O DEERFIELD MANAGEMENT COMPANY, L.P., 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK, NEW YORK, 10010
Covered Properties (53)
Heterocyclic Compounds and Uses Thereof
Application: 61/622,259 →
Heterocyclic Compounds and Uses Thereof
Application: 61/713,404 →
Heterocyclic Compounds and Uses Thereof
Patent: 8,940,742 →
Application: 13/841,265 →
Publication: US 2013/0267521
Heterocyclic Compounds and Uses Thereof
Patent: 9,255,108 →
Application: 14/573,961 →
Publication: US 2015/0105385
Heterocyclic Compounds and Uses Thereof
Application: 61/887,243 →
Heterocyclic Compounds and Uses Thereof
Patent: 9,751,888 →
Application: 15/026,947 →
Publication: US 2016/0222016
Heterocyclic Compounds and Uses Thereof
Application: 61/887,259 →
Heterocyclic Compounds and Uses Thereof
Application: 61/888,958 →
Heterocyclic Compounds and Uses Thereof
Application: 61/938,026 →
Heterocyclic Compounds and Uses Thereof
Patent: 9,359,365 →
Application: 14/506,429 →
Publication: US 2015/0111874
Heterocyclic Compounds and Uses Thereof
Patent: 9,828,377 →
Application: 14/695,699 →
Publication: US 2015/0225410
Heterocyclic Compounds and Uses Thereof
Application: 15/794,816 →
Publication: US 2018/0044346
Heterocyclic Compounds and Uses Thereof
Application: 17/202,195 →
Publication: US 2022/0372038
Heterocyclic Compounds and Uses Thereof
Application: 62/059,426 →
Heterocyclic Compounds and Uses Thereof
Application: 62/216,261 →
Trisubstituted Bicyclic Heterocyclic Compounds with Kinase Activities and Uses Thereof
Patent: 9,708,348 →
Application: 14/874,328 →
Publication: US 2016/0122365
Heterocyclic Compounds and Uses Thereof
Application: 15/621,815 →
Publication: US 2017/0369511
Heterocyclic Compounds and Uses Thereof
Application: 16/290,545 →
Publication: US 2019/0330240
Heterocyclic Compounds and Uses Thereof
Application: 61/955,717 →
Heterocyclic Compounds and Uses Thereof
Application: 61/980,484 →
Heterocyclic Compounds and Uses Thereof
Application: 62/000,923 →
Heterocyclic Compounds and Uses Thereof
Application: 62/033,008 →
Heterocyclic Compounds and Uses Thereof
Application: 62/059,766 →
Heterocyclic Compounds and Uses Thereof
Application: 62/075,173 →
Heterocyclic Compounds and Uses Thereof
Application: 62/101,980 →
Heterocyclic Compounds and Uses Thereof
Patent: 9,775,844 →
Application: 14/661,656 →
Publication: US 2015/0290207
Heterocyclic Compounds and Uses Thereof
Application: 15/672,964 →
Publication: US 2018/0055852
Heterocyclic Compounds and Uses Thereof
Application: 16/816,132 →
Publication: US 2021/0000837
Heterocyclic Compounds and Uses Thereof
Application: 18/072,314 →
Publication: US 2024/0050437
Solid Forms of Isoquinolinones and Composition Comprising and Methods of Using the Same
Application: 62/218,493 →
Solid Forms of Isoquinolinones, and Process of Making, Composition Comprising, and Methods of Using the Same
Application: 15/264,417 →
Publication: US 2017/0088553
Solid Forms of Isoquinolinones, and Process of Making, Composition Comprising, and Methods of Using the Same
Application: 16/197,195 →
Publication: US 2019/0185477
Solid Forms of Isoquinolinones, and Process of Making, Composition Comprising, and Methods of Using the Same
Application: 17/578,309 →
Publication: US 2022/0135576
Process for Making Amorphous Form of Isoquinolinones and Composition Comprising and Methods of Using the Same
Application: 62/218,486 →
Isotopologues of Isoquinolinone and Quinazolinone Compounds and Uses Thereof
Application: 62/309,769 →
Isotopologues of Isoquinolinone and Quinazolinone Compounds and Uses Thereof as PI3K Kinase Inhibitors
Application: 16/085,536 →
Publication: US 2019/0202835
Heterocyclic Compounds and Uses Thereof
Application: 62/347,539 →
Heterocyclic Compounds and Uses Thereof
Application: 16/308,377 →
Publication: US 2019/0135833
Heterocyclic Compounds and Uses Thereof
Application: 63/122,892 →
Heterocyclic Compounds and Uses Thereof
Application: 63/146,470 →
Methods for Treating Cancer
Application: 63/168,123 →
Methods for Treating Cancer
Application: 63/203,515 →
Eganelisib for Use in the Treatment of Pd-L1 Negative Cancer
Application: 18/265,915 →
Publication: US 2024/0050432
Solid Forms of Isoquinolinones, and Process of Making, Composition Comprising, and Methods of Using the Same
Application: 18/583,627 →
Publication: US 2024/0317763
Heterocyclic Compounds and Uses Thereof
Heterocyclic Compounds and Uses Thereof
Heterocyclic Compounds and Uses Thereof
Heterocyclic Compounds and Uses Thereof
Heterocyclic Compounds and Uses Thereof
Solid Forms of Isoquinolinones, and Process of Making, Composition Comprising, and Methods of Using the Same
Isotopologues of Isoquinolinone and Quinazolinone Compounds and Uses Thereof
Heterocyclic Compounds and Uses Thereof
Methods for Treating Cancer
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 20, 2012
From: REN, PINGDA; LIU, YI; LI, LIANSHENG; CHAN, KATRINA
To: INTELLIKINE, INC.
Reel/Frame 028407/0410 →
Assignment of Assignor's Interest Jun 20, 2012
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A., MS.; SNYDER, DANIEL A., MR.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 028407/0573 →
Change of Name Nov 13, 2012
From: INTELLIKINE, INC.
To: INTELLIKINE LLC
Reel/Frame 029294/0621 →
Assignment of Assignor's Interest Jan 14, 2013
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A.; SNYDER, DANIEL A.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 029622/0515 →
Assignment of Assignor's Interest Mar 4, 2013
From: REN, PINGDA; LIU, YI; LI, LIANSHENG; CHAN, KATRINA
To: INTELLIKINE LLC
Reel/Frame 029912/0840 →
Assignment of Assignor's Interest Jun 11, 2013
From: INTELLIKINE LLC
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 030590/0539 →
Assignment of Assignor's Interest Jul 3, 2013
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A.; JANARDANANNAIR, SOMARAJANNAIR; LESCARBEAU, ANDRE
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 030735/0670 →
Assignment of Assignor's Interest Aug 12, 2013
From: CHAN, KATRINA; LI, LIANSHENG; LIU, YI; REN, PINGDA
To: INTELLIKINE LLC
Reel/Frame 030992/0634 →
Assignment of Assignor's Interest Oct 16, 2013
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A.; JANARDANANNAIR, SOMARAJANNAIR; LESCARBEAU, ANDRE
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 031417/0068 →
Assignment of Assignor's Interest Oct 16, 2013
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A.; JANARDANANNAIR, SOMARAJANNAIR; LESCARBEAU, ANDRE
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 031416/0664 →
Assignment of Assignor's Interest Dec 9, 2013
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A.; JANARDANANNAIR, SOMARAJANNAIR; LESCARBEAU, ANDRE
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 031742/0954 →
Assignment of Assignor's Interest Jun 23, 2014
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A.; JANARDANANNAIR, SOMARAJANNAIR; LESCARBEAU, ANDRE
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 033161/0236 →
Assignment of Assignor's Interest Jun 23, 2014
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A.; JANARDANANNAIR, SOMARAJANNAIR; LESCARBEAU, ANDRE
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 033161/0299 →
Assignment of Assignor's Interest Jun 23, 2014
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A.; JANARDANANNAIR, SOMARAJANNAIR; LESCARBEAU, ANDRE
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 033160/0970 →
Assignment of Assignor's Interest Jun 23, 2014
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A.; JANARDANANNAIR, SOMARAJANNAIR; LESCARBEAU, ANDRE
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 033161/0143 →
Assignment of Assignor's Interest Sep 25, 2014
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A.; JANARDANANNAIR, SOMARAJANNAIR; LESCARBEAU, ANDRE
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 033826/0268 →
Assignment of Assignor's Interest Mar 5, 2015
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A.; JANARDANANNAIR, SOMARAJANNAIR; LESCARBEAU, ANDRE
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 035096/0830 →
Assignment of Assignor's Interest Mar 5, 2015
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A.; JANARDANANNAIR, SOMARAJANNAIR; LESCARBEAU, ANDRE
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 035096/0937 →
Assignment of Assignor's Interest Mar 5, 2015
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A.; JANARD ANANNAIR, SOMARAJANNAIR; LESCARBEAU, ANDRE
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 035094/0679 →
Assignment of Assignor's Interest Mar 13, 2015
From: CASTRO, ALFREDO C.; EVANS, CATHERINE A.; TREMBLAY, MARTIN R.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 035166/0924 →
Assignment of Assignor's Interest Mar 16, 2015
From: KUTOK, JEFFERY L.; WINKLER, DAVID G.; PALOMBELLA, VITO J.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 035175/0777 →
Assignment of Assignor's Interest Mar 16, 2015
From: KUTOK, JEFFERY L.; WINKLER, DAVID G.; PALOMBELLA, VITO J.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 035175/0521 →
Assignment of Assignor's Interest Mar 16, 2015
From: KUTOK, JEFFERY L.; WINKLER, DAVID G.; PALOMBELLA, VITO J.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 035175/0049 →
Assignment of Assignor's Interest Mar 16, 2015
From: KUTOK, JEFFERY L.; WINKLER, DAVID G.; PALOMBELLA, VITO J.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 035174/0671 →
Assignment of Assignor's Interest Mar 16, 2015
From: KUTOK, JEFFERY L.; WINKLER, DAVID G.; PALOMBELLA, VITO J.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 035173/0319 →